PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances...

72
᾽᾽Nätdroger᾽᾽ Erik Lindeman läkare Giftinformationscentralen

Transcript of PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances...

Page 1: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

᾽᾽Nätdroger᾽᾽

Erik Lindeman läkare

Giftinformationscentralen

Page 2: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

”Nätdroger”

Nya Psykoaktuiva Substanser

Läkemedel som aldrig blev nåt

Indragna läkemedel

Farmakologiska prober

Veterinärmedicinska preparat

Modifierade kända narkotikasubstanser

Page 3: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.
Page 4: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Lagstiftning

• Pfizerpatentet = 728 molekyler där det centrala heterocykliska ringsystemet är en indazol.

• MDMB-CHMICA = derivat där ringsystemet i en av molekylerna substituerats med indol.

• Förmodligen behåller molekylerna sin aktivitet på CB1-receptorn även med andra substitutioner (eg benzimidazol).

• 728 x 2 = 1456

• 728 x 3 =2184

Page 5: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Lagstiftning

• Folkhälsomyndigheten utreder substanser på individuell basis och föreslår narkotikaklassning (regeringen lagstiftar)

• Med dagens takt (ca 20 cannabinoider/6 mån) räcker pfizerpatentet i 55 år.

Page 6: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Lagstiftning

• Generisk narkotikaklassning: patentet visar –in sich- att det är görbart

• Storbritannien har haft ”familjeklassning” av cannabinoider sedan 2009, uppdaterad 2012. Skyddade ej mot pfizerpatentet…

• Neurokemisk approach: allt med en definierad förmåga att aktivera en definierad receptor = nartkotika oavsett struktur.

https://www.gov.uk/government/publications/circular-0042016-psychoactive-substances-act-2016: Psychoactive Substances Act 2016: Forensic Strategy

Page 7: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Lagstiftning

The ACMD has recommended two tests:

• (1) receptor binding assay (to determine whether the drug binds to the receptor); and

• (2) a functional assay (to determine whether the drug activates a response following interaction with the receptor).

• Möjliga receptorer: CB1, µ, GABA mfl.

https://www.gov.uk/government/publications/circular-0042016-psychoactive-substances-act-2016: Psychoactive Substances Act 2016: Forensic Strategy

Page 8: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger

Page 9: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nya Zeeland 2013 = 4000 ”nätdrogskiosker”

Page 10: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Förstörandelagen

Page 11: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger

Page 12: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger

Page 13: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nya droger i Europa

EMCDDA: New psychactive substances in Europe March 2015

Page 14: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Data från GIC

Page 15: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Data från GIC

0

200

400

600

800

1000

1200

1400

1600

1800

An

tal

förf

råg

nin

ga

r

År

GIFTINFORMATIONSCENTRALEN 2000 - 2016

Amfetamin

Cannabis

Ecstasy

GHB

Kokain

LSD

Opioider

Drog i drink

Hallucinogena svampar

Övrigt

Page 16: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Hawthorn effekten

Hawthornfabriken IIIinois (USA)

Page 17: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

STRIDA 2009-2016. R.I.P

Läkartidningen 2011-07-05

Page 18: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Mycket droger!

Spice MDPV

Kannibaldrogen

3-MMC

Mephedron

5-IT Badsalt

5F-AB-FUBINACA

Page 19: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Vi förenklar: 3 droger

᾽᾽badsalt᾽᾽

᾽᾽spice᾽᾽

”killers”

Page 20: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Badsalt = syntetiska katinoner

Page 21: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Fenetylamin = grundbulten

Fenetylamin Amfetamin MDMA (ecstasy) Metamfetamin

Page 22: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Badsalt = syntetiska katinoner

Amfetamin Katinon

Page 23: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Badsalt = Syntetiska katinoner

Page 24: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Badsalt = Syntetiska katinoner

20% av alla NPS ofta > 50% av NPS-beslag

Page 25: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Monoaminerga system

Locus Coeruleus - Noradrenalin vakenhet, uppmärksamhet

Ventral Tegment Area - Dopamin belöning, motivation, begär

Raphae - Serotonin Stämningsläge, tillfredsställelse

Page 26: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Monoaminerga system

Page 27: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Monoaminerga system

Målorgan för läkemedel:

• Antidepressiva (TCA, SSRI, SNRI)

• ADHD-mediciner (ritalina, amfetamin)

• Neuroleptika (haldol)

Page 28: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Monoaminerga system

Målorgan för narkotika:

• Psykostimulantia:

– Amfetamin

• Eufori, ökad vakenhet, adrenergt påslag

• Ego-inflation

Page 29: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Monoaminerga system

Målorgan för narkotika:

• Empatogener:

– Ecstasy

• Eufori, ökad vakenhet, adrenergt påslag

• Ökad empati

Page 30: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Empatogener vs psykostimulantia

Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling. SMW 2015;145:w14043

Page 31: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Vi förenklar: 3 droger

᾽᾽badsalt᾽᾽

᾽᾽spice᾽᾽

”killers”

Page 32: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

”Spice” = Syntetiska cannabinoider

40% av alla NPS

ofta > 50% av NPS-beslag

Page 33: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Spice - fall

• Tre män som samtliga vistas på ett behandlingshem för narkotikamissbrukare uppsöker personalen påtagligt förvirrade

• Uppger att de tagit ”krokodil”, ”spice” eller ”badsalt”

• Samtliga börjar kräkas och faller ihop med epileptiska kramper

Page 34: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

• Samtliga fortsätter att ha epileptiska kramper under ambulanstransporten till sjukhus

• Samtliga behöver assisterad andning (med mask och blåsa) under transporten

• Två av patienterna behöver vård i respirator över natten

• En patient vaknar på akutrummet

Spice - fall

Page 35: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

• Först ett år efter incidenten har analysmetod för att detektera den inblandade substansen utvecklats…

”MDMB-CHMICA”

Spice - fall

Page 36: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Pfizerpatentets barn

”MDMB-CHMICA”

5-10% av alla sjukvårds- kontakter till GIC

Page 37: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

0

200

400

600

800

1000

1200

1400

1600

1800

An

tal

förf

råg

nin

ga

r

År

GIFTINFORMATIONSCENTRALEN 2000 - 2016

Amfetamin

Cannabis

Ecstasy

GHB

Kokain

LSD

Opioider

Drog i drink

Hallucinogena svampar

Övrigt

Page 38: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

MDMB-FUBINACA

N

N

NH

O

O

F

O

AB-FUBINACA

N

N

NH

O

F

O NH2

ADB-CHMINACA

N

N

NH

O

O NH2

AB-CHMINACA

N

N

NH

O

O NH2

MDMB-CHMINACA

N

N

NH

O

O O

MDMB-CHMICA

N

NH

O

OO

Pfizerpatentets barn

Page 39: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Pfizerpatentets barn

Page 40: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Syntetiska cannabinoider

• THC = den huvudsakliga ”naturliga cannabinoiden”

• THC = partiell agonist på CB1-recepton

• ”spice” = fulla agonister på CB1-receptron + HÖG affinitet ”spice”= THC x 5-10 (- 100)

Page 41: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

SEX dödsfall med MDMB-CHMICA i blodet hösten 2014 TVÅ där inga andra möjliga bidragande dödsorsaker hittats

Page 42: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

De farligaste drogerna leder till

• Andningsstillestånd eller medvetslöshet med risk för kvävning

• De drabbade dör utanför sjukhus

Page 43: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

16 Juni 2015

Page 44: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nu ”fentanylderivat” (butyrfentanyl, acetylfentanyl, furanylfentanyl mm).

Ca 1-2 (-10!) GIC-samtal/vecka hur många dödsfall??

”Nätopioider”

Page 45: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.
Page 46: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Carfentanil

Elefantbedövningsmedel

100µg per os andningsdepression hos chimpans

Ingen robust erfarenhet av effekter på människa Nebuliserat carfentanil användes av Spetsnaz vid gisslandramat på Dubrovkateatern 2002. 127/800 dog, 650/800 fick sjukhusvårdas

Lust et al. Human health hazards of veterinary medications: information for emergency departments. J Emerg Med. 2011;40(2):198-207

Page 47: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.
Page 48: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Vi förenklar: tre fenotyper

1. Andningspåverkan

2. Agiterat delirium

3. Serotonergt syndrom

Page 49: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger: fenotyp 2

Agiterat Delirium

Page 50: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger agitation och förvirring!

• Många typer av nätdroger kan ge upphov till ångest, agitation och förvirring i varierande grad!

Page 51: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger agitation och förvirring!

• Många typer av nätdroger kan ge agiterat delirium

• Droger som stimulerar dopamin störst risk för fullskaligt AGITERAT DELIRIUM

Page 52: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Vad alla MÅSTE förstå:

Agitation är farligt!

Page 53: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Simulerad “gripandesituation”

Brottning med “heavy bag”:

• pH 7.06 (efter vila i 10 min)

• Laktat 18 mmol/L (efter vila i 10 min)

Ho et al. Acidosis and cathecolamine evaluation following simulated law enforcement “use of force” encounters. Acad Emerg Med 2010;17:E60-8

Page 54: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Verklig “gripandesituation”

Kompression av thorax:

• Koldioxidretention dekompenserad acidos

• Hypoxi laktatbildning, risk för arytmier

Page 55: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Verklig “gripandesituation”

Kompression av vena cava inferior:

• Minskat venöst återflöde bradykardi/asystoli (“Bezold-Jarish reflexen”)

Ingemar Thiblin: Dödsfall vid polisingripande, PHS serie i polisiärt arbete 2011:1

Page 56: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

MDPV

• Katinonderivat

• Saknar nästan helt aktivitet på serotoninsystemet

• Dopaminselektivt! 10 x mera potent än kokain

Page 57: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

MDPV ökat vårdbehov i Västerås

Ökat missbruk av internetdrogen MDPV i Västmanland. Lindeman et al, Läkartidningen Okt 2012

Page 58: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Behandling av Agiterat Delirium

Indikationen för intensivvård står i direkt proportion till antalet poliser/väktare som sitter på patienten!

Page 59: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Behandling av Agiterat Delirium

SEDERA PATIENTEN

Använd

– Bensodiazepiner iv

– Neuroleptika im

– Propofol vb

Page 60: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Ketalar?

• Ketamin (50mg/ml): 5mg/kg im kan övervägas vid uttalad agitation där intravenös infart ej kan etableras

Page 61: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Don’ts

• Bältesläggning är FARLIGT

• Anv. INTE β-BLOCKAD (risk för hjärtsvikt)

• Missa inte DIFF-DIAGNOSER (hypoglykemi, skall-trauma, infektion mm)

• MONITORERA sederad patient (andning, cirk, temp)

Page 62: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Nätdroger: fenotyp 3

Serotonergt Syndrom

Page 63: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Serotonergt syndrom

• Agitation, förvirring

och takykardi vanligt

liksom vid AD

• + pat ”sprittiga”

– ökade senreflexer

– tremor

– klonus (även okulär)

– muskelstelhet

• Hypertermi - SVÅR

Dunkley et al. The Hunter serotonin toxicity criteria: simple and accurate diagnostic desicion rules for serotonin toxicity. Q J Med 2003;96:635-42

Page 64: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Serotonergt syndrom

• Empatogener frisätter

serotonin risk

• Vissa varianter =

serotoninfrisättande +

MAO-hämmare

• Risk för livshotande

hypertermi och

multiorgansvikt

Page 65: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Serotonergt syndrom

Rusyniak et al. Toxin-induced hyperthermic syndromes. Med Clin N Am. 2005;89:1277-1296 Mills et al. Uncoupling the agony from ecstasy. Nature 2003;426:403-4

Page 66: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Serotonergt syndrom

Anisolja (anethol)

Page 67: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Serotonergt syndrom

• PMMA

– 27 döda i Norge 2010-12

– 24 döda i Israel 2007-08

– 27 döda i Kanada 2011-12

• 5-IT

– 14 döda i Sverige 2012

• 4,4’-DMAR

– 19 döda på Nordirland 2013

”Rosa superman” julen 2014 – 15 = sju svenska dödsfall (på en vecka).

Page 68: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Metedron

• 24-årig man besöker

en kompis

• Försvinner in i

duschen i 30 minuter

• Skrik hörs & pat

påträffas medvetslös

och muskelstel

Wikström et al. Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J Anal Toxicol. 2010 Nov;34(9):594-8.

Page 69: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Metedron

• På akutrummet temp

42°, puls 180,

blodtryck 55 och

SpO2 80%.

• Multiorgansvikt,

avlider i asystoli 16

timmar efter ankomst

• Rättsmedicin:

β-keto PMMA

Wikström et al. Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J Anal Toxicol. 2010 Nov;34(9):594-8.

Page 70: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Serotonergt syndrom

Gowing et al. The Health effects of ecstasy: a litterature review. Drug Alcohol Rev 2002;21:53-63

Page 71: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Värmeslag

• Core temperture > 40°+ CNS-symptom (agitation/kramper/koma)

• Aktivering av inflammatoriska kaskadsystem multiorgansvikt

• DIC, ARF, ARDS rabdomyolys, hjärtsvikt, leverskada

• Mortalitet 50%

• Överlevare ofta permanenta neurologiska skador

Bouchama, Knochel Heat Stroke. NEJM 2002;346(25):1978-88

Page 72: PowerPoint-presentation...Empatogener vs psykostimulantia Liechi. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoaminergic signalling.

Ice water submersion for rapid cooling in severe drug-induced hyperthermia

Laskowski et al. Clin Tox 2015;53:181-84